Por: New York Post Tech June 29, 2023
The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently referred to as INS018 055, is being tested to treat idiopathic pulmonary fibrosis (IPF), a rare, progressive type of chronic lung disease. The 12-week trial will include participants diagnosed with IPF. “This drug, which will be... + full article
ABC News USA Health March 17, 2023
A new double lung transplant technique was successful for two patients with lung cancer, Northwestern Medicine announced. The hospital said it's leveraging that success into a new clinical program that will offer transplants to patients with end-stage lung cancer.Every... + más
Lung Cancer Screening Can Catch Tumors When They're Curable, New Research Finds | Time
Even patients at low risk can develop lung cancer | WPLG Local 10
CNBC USA Health February 16, 2023
In this articlewatch nowVIDEO2:2302:23Drug makers are looking to drive diversity in clinical trialsSharon Kimbrough went to the Black Women's Expo in Atlanta to sell her memoir. Getting tested for Alzheimer's was the furthest thing on her mind, but when nurses from... + más
As Eli Lilly Gears Up For Growth, Its CFO Prescribes Leading Indicators | Forbes
Eli Lilly's Alzheimer’s Drug Donanemab Fails to Get Early FDA Approval | Time
The New York Times USA Business January 27, 2023
For individuals suffering from a deadly disease, clinical trials for drugs offer lifesaving hope. But for all the rapid advances in science and medicine, some of the building blocks of clinical trials — the back-end technology, data aggregation and patient recruitment —... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
Shocked By Disparities In Access To Clinical Trials, This Medical Student Decided To Change Things | Forbes
Forbes USA Business January 17, 2023
Lung cancer is a devastating disease. According to the , lung cancer is one of the most common causes of death worldwide, accounting for nearly 2.21 million cases in 2020 alone. Importantly, the disease can be progressive; that is, for many, it may start out as just mild... + más
Sally Kornbluth named next MIT president | The Boston Globe
Time USA Health November 28, 2022
For the past six years, Elyssa Barbaro has gotten screened for . The 71-year-old New Yorker for about 50 years, but she doubts she would have gotten an annual preventative CT scan if her pulmonologist hadn’t told her she should. Even though the procedure takes just 15 minutes,... + más
A New Approach to Spotting Tumors: Look for Their Microbes | The New York Times
Lost In Translation In RCT Colonoscopy Study: Some Kind Of Colorectal Cancer Screening Is Essential To Lower Mortality Rates | Forbes
Forbes USA Tech November 11, 2022
, Chief Experience Officer, THREAD Research. getty The Elephant In The Drug Development Room Clinical trials are the FDA-mandated process by which pharmaceutical companies confirm that the efficacy and safety of their new drugs make them worthy of government approval, then... + más
Council Post: 'Stayin' Alive': Patient Centricity In Decentralized Clinical Trials | Forbes
Forbes USA Business October 03, 2022
Greenphire is working to make clinical trials more equitable and accessible to everyone. Google Images Clinical trial company Greenphire as “the leading provider of global financial lifecycle management solutions for clinical trials, delivering the most complete data and... + más
Market turbulence, inflation, geopolitical uncertainty prompt dip in fintech investment: KPMG | Fox Business
Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate
About iurex | Privacy Policy | Disclaimer |